Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:52 PM
Ignite Modification Date:
2025-12-24 @ 6:52 PM
NCT ID:
NCT05236257
Eligibility Criteria:
Inclusion Criteria:
* Age ≤ 21 years old.
* Locally advanced or metastatic Infantile Fibrosarcoma (IFS).
* Identification of an NTRK gene fusion by a molecular biology assay.
* Patients with available information on clinical, radiological characteristics of their tumor, therapies administered and outcomes.
* Patients receiving larotrectinib in the SCOUT trial.
* Patients receiving at least chemotherapy drugs in the historical control cohort(s).
* No opposition from the patients and/or representatives for data use.
Exclusion Criteria:
* Patients treated with TRK inhibitors in the historical control cohort(s).
* Patients with documented absence of NTRK gene fusion.
* Patients participating in an investigational program with interventions outside of routine clinical practice.
Sex:
ALL
Maximum Age:
21 Years
Study:
NCT05236257
Study Brief:
Protocol Section:
NCT05236257